(Y46.2) Hydantoin derivatives

More details coming soon

Icon
24 262 in individuals diagnosis hydantoin derivatives confirmed
Icon
2 651 deaths with diagnosis hydantoin derivatives
Icon
11% mortality rate associated with the disease hydantoin derivatives

Diagnosis hydantoin derivatives is diagnosed Women are 27.64% more likely than Men

8 778

Men receive the diagnosis hydantoin derivatives

0 (less than 0.1%)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
15 484

Women receive the diagnosis hydantoin derivatives

2 651 (17.1 %)

Died from this diagnosis.

Risk Group for the Disease hydantoin derivatives - Men aged 25-29 and Women aged 60-64

Icon
In Men diagnosis is most often set at age 0-5, 25-39, 50-59, 70-74
Icon
Less common in men the disease occurs at Age 0-1, 5-24, 40-49, 60-69, 75-95+Less common in women the disease occurs at Age 0-1, 5-34, 45-49, 85-95+
Icon
In Women diagnosis is most often set at age 0-5, 35-44, 50-84

Disease Features hydantoin derivatives

Icon
Absence or low individual and public risk
Icon

Hydantoin derivatives - what does this mean

Hydantoin derivatives are a class of drugs that act as anticonvulsants and are used to treat certain types of seizures. these drugs work by blocking certain sodium channels in the brain, which helps to reduce the frequency and severity of seizures. they can also be used to prevent seizures in people with a history of epilepsy.

What happens during the disease - hydantoin derivatives

Hydantoin derivatives are a class of drugs that are used to treat a variety of conditions, including seizures, anxiety, and depression. they work by inhibiting the reuptake of serotonin and norepinephrine, two neurotransmitters that play an important role in regulating mood. by blocking their reuptake, the drugs can increase the levels of these neurotransmitters in the brain, resulting in an improved mood and decreased symptoms of depression and anxiety. in addition, they may also reduce seizure activity by decreasing the excitability of neurons in the brain.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Physical examination
  • Laboratory tests for serum levels of the drug
  • Imaging studies such as X-rays or CT scans
  • Urine tests for metabolites of the drug
  • Genetic testing for mutations associated with hydantoin derivatives
  • Endoscopic examination
  • Skin biopsy
  • Tissue sampling

Treatment and Medical Assistance

Main goal of the treatment: To reduce the symptoms associated with Hydantoin derivatives.
  • Prescribe medications that reduce the symptoms of Hydantoin derivatives
  • Provide dietary and lifestyle advice to reduce the symptoms of Hydantoin derivatives
  • Monitor the patient's condition and adjust medications as needed
  • Refer the patient to specialists for further treatment if needed
  • Educate the patient and family about the disease and how to manage it
Icon
13 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Hydantoin derivatives - Prevention

Hydantoin derivatives can be prevented by avoiding contact with contaminated water sources, practicing good hygiene, and using appropriate protective gear when handling potentially contaminated materials. vaccines are also available for some types of hydantoin derivatives.